GUIDEPOINT INSIGHTS ASCO COVERAGE

From June 4th-8th Guidepoint Insights will be hosting a series of teleconferences (transcripts available post-call) and virtual group meetings (live event only, no transcript) featuring KOLs who will dive deeper into clinical updates from this year’s ASCO conference.

Please select the teleconferences and group meetings you would like to participate in by completing the form below and clicking “submit” at the bottom of the page.

 

    Monday, June 7th
    (50-Minute Group Meetings - Live Event Only, No Transcript)
    9:00 AM ET - Roman Groisberg
    Sarcomas and Novel Developmental Therapies | Medical Oncologist at Rutgers Cancer Institute of New Jersey
    10:00 AM ET - Joshua Brody
    Lymphomas | Associate Professor in Hematology and Medical Oncology & Director of the Lymphoma Immunotherapy Program at Mount Sinai Medical Center
    10:30 AM ET - David Sallman
    Leukemias | Assistant Member at H. Lee Moffitt Cancer Center & Research Institute, Inc.
    11:00 AM ET - Scott Tagawa
    GU Cancer | Professor at Weill Cornell Medical College, New York
    11:00 AM ET - Tejas Patil
    NSCLC Targeted Therapy | Assistant Professor at The University of Colorado
    12:00 PM ET - Mark Awad
    Lung Cancer | Clinical Director, Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, Inc.
    1:00 PM ET - Kevin Kalinsky
    Breast Cancer | Professor and Chair, Department of Hematology & Medical Oncology, Chief Medical Officer at Winship Cancer Institute of Emory University
    1:00 PM ET - Ran Reshef
    Cell Therapy | Director of Translational Research, Blood and Marrow Transplantation Clinical Lead, CAR-T Cell Program, Associate Professor of Medicine at Columbia University Medical Center
    3:00 PM ET - Thomas Marron
    Immuno-Oncology | Director of the Early Phase Trials Unit at Icahn School of Medicine at Mount Sinai
    Tuesday, June 8th
    (50-Minute Group Meetings - Live Event Only, No Transcript)
    10:00 AM ET - William Matsui
    Hematologic Malignancies | Professor of Oncology, Vice Chair of Research at The Dell Medical School
    10:00 AM ET - Aurelien Marabelle
    Immuno-oncology | Clinical Director, Cancer Immunotherapy Program at Institut de cancérologie Gustave Roussy
    11:00 AM ET - Michael Morse
    GI Cancers | Professor of Medicine at Duke University Health System, Inc.
    12:00 PM ET - Joshua Sasine
    Cell Therapy and Hematological Malignancies | Staff Physician, Founder of the CAR T Program at Cedars-Sinai Health System
    12:00 PM ET - Tanguy Seiwert
    Lung Cancer | Assistant Professor and Director of Head and Neck Oncology Disease Group at Johns Hopkins University
    1:00 PM ET - Eric Jonasch
    GU Cancer | Professor, Department of Genitourinary Medical Oncology for the Division of Cancer Medicine at University of Texas MD Anderson Cancer Center
    2:00 PM ET - Joshua Sabari
    Lung Cancer | Medical Oncologist at NYU Langone Medical Center LLC
    4:00 PM ET - Timothy Yap
    DDR and Novel Developmental Therapies | Medical Director at The University of Texas MD Anderson Cancer Center
    30-Minute Teleconferences - Transcripts Available

    Friday, June 4th
    10:00 AM ET - Iovance TILs Update
    Medical Oncologist/Assistant Attending Physician, Melanoma Service, Memorial Sloan Kettering Cancer Center
    10:00 AM ET - Adjuvant Pembrolizumab in RCC, ARTISTRY-1, and TIVO-3 Trial
    Professor, Department of Genitourinary Medical Oncology for the Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
    12:00 PM ET - Spectrum Pharmaceuticals and Cullinan Oncology EGFR Exon 20 Inhibitor Data in NSCLC
    Associate Professor, Mayo Clinic Arizona
    12:30 PM ET - Review of ELEVATE-RR (Imbruvica vs Calquence) & Other Imbruvica Updates (RESONATE-2 & CAPTIVATE)
    Assistant Professor, The Mount Sinai Medical Center, Inc.
    1:00 PM ET - Monjuvi L-MIND and First-MIND Review
    Professor of Medicine and Head of the Lymphoma Program, Sylvester Comprehensive Cancer Center at the University of Miami
    1:00 PM ET - Fate Therapeutics' FT516 in DLBCL
    Oncologist and Clinical Director of the Cellular Immunotherapy Program, Massachusetts General Hospital
    2:00 PM ET - Epcoritamab Update
    Director of Translational Research, Blood and Marrow Transplantation Clinical Lead, CAR-T Cell Program, Associate Professor of Medicine, Columbia University Medical Center
    2:45 PM ET - TIGIT update from BeiGene, Compugen's Anti-PVRIG, and iTeos' A2AR Antagonist
    Director of Immunotherapeutics Center, UPMC Hillman Cancer Center
    3:00 PM ET - Zenocutuzumab Bispecific and KN046 in Pancreatic Cancer
    Professor of Medicine, Duke University Health System, Inc.
    3:00 PM ET - Blueprint Medicines' Pralsetinib ARROW Trial Updates in RET+ NSCLC
    Professor, University of Colorado Denver
    3:30 PM ET - Updated Lumakras CodeBreaK Data
    Assistant Professor of Medicine, Harvard Medical School
    4:30 PM ET - CAR-Ts in Multiple Myeloma
    Director, Immune Effector Cell Therapy, attending physician, Bone Marrow Transplant and Medical Oncology, Intermountain Healthcare, Inc.
    5:00 PM ET - Adaptimmune's TCR-Ts in Synovial Sarcoma
    Medical Oncologist, Rutgers Cancer Institute of New Jersey
    Sunday, June 6th
    3:00 PM ET - Bristol Myers Squibb's LAG3 Plus Nivo Data in Melanoma
    Assistant Professor, The University of Texas MD Anderson Cancer Center

     

    ASCO 30-minute teleconference transcripts will be available 48 hours after the call ends. Group meetings will not be recorded and transcripts will not be available after the event. To recreate conditions similar to an in-person meeting, group meetings will be conducted via Zoom. As such, participants will be able to see/identify each other.

    For more details on our ASCO events, please email Alyssa Vozza at avozza@guidepoint.com.